Coinbase, one of the leading cryptocurrency exchanges, has taken a significant step towards expanding its derivatives offerings by filing for self-certification to list Solana (SOL) futures contracts.
Coinbase Derivatives, a subsidiary of the crypto exchange, has filed documents with the Commodity Futures Trading Commission (CFTC) to list Solana (SOL) and Hedera (HBAR) futures. The exchange plans to launch the product on Feb 18., with new contracts being cash-settled on a monthly basis, according to the filing.
Coinbase Derivatives, a subsidiary of Coinbase launched in June 2021, is making a significant move to expand its offerings. On January 30, the entity filed
The crypto exchange aims to launch $25,000 SOL derivatives, betting on institutional appetite as the token's volatility soars.
Coinbase Derivatives, LLC has submitted a self-certification to the CFTC for the listing of Solana (SOL) futures contracts.
Coinbase CEO Brian Armstrong wrote in a post on X that an issue causing Coinbase users to experience delays and cancellations of Solana transactions had been “tria
Solana's stablecoin supply has surged by 73% in just 15 days, driven by the launch of TRUMP and MELANIA meme coins.
Coinbase Exchange has continued to face backlash from users over transaction delays relating to the Solana blockchain.
Coinbase users have experienced significant delays with Solana transactions following the launch of memecoins by former President Donald Trump and his wife Melania.
Solana's native token reached an all-time high after launching the $TRUMP token on the blockchain. The trend might happen again.
Catch the Stage 8 presale of the 5th-best ICO of the decade, DTX Exchange, with $13.2 million raised and the anticipation of a token surge to $0,20. Learn more.
The U.S. Securities and Exchange Commission (SEC) has expedited approval for Bitwise Asset Management's Bitcoin and Ethereum exchange-traded fund (ETF). This decision allows the ETF to be listed and traded on NYSE Arca, marking a major milestone for crypto-based investment products.